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Abstract
Farmers face difficulties in redeeming their investment in larger litter sizes since this comes
with larger litter heterogenicity, lower litter resilience and risk of higher mortality. Dietary oli-
gosaccharides, given to the sow, proved beneficial for the offspring’s performance. How-
ever, giving oligosaccharides to the suckling piglet is poorly explored. Therefore, this field
trial studied the effect of dietary short-chain fructo-oligosaccharides (scFOS; 1g/day;
drenched) supplementation to low (LBW, lower quartile), normal (NBW, two intermediate
quartiles) and high (HBW, upper quartile) birth weight piglets from birth until 7 or 21 days of
age. Performance parameters, gut microbiome and short-chain fatty acids profile of feces
and digesta were assessed at birth (d 0), d 7, weaning (d 21.5) and 2 weeks post-weaning
(d 36.5). Additional parameters reflecting gut health (intestinal integrity and morphology,
mucosal immune system) were analysed at d 36.5. Most parameters changed with age or
differed with the piglet’s birth weight. Drenching with scFOS increased body weight by 1 kg
in NBW suckling piglets and reduced the post-weaning mortality rate by a 100%. No clear
difference in the IgG level, the microbiota composition and fermentative activity between the
treatment groups was observed. Additionnally, intestinal integrity, determined by measuring
intestinal permeability and regenerative capacity, was similar between the treatment groups.
Also, intestinal architecture (villus lenght, crypt depth) was not affected by scFOS supple-
mentation. The density of intra-epithelial lymphocytes and the expression profiles (real-time
qPCR) for immune system-related genes (IL-10, IL-1ß, IL-6, TNFα and IFNγ) were used to
assess mucosal immunity. Only IFNγ expression, was upregulated in piglets that received
scFOS for 7 days. The improved body weight and the reduced post-weaning mortality seen
in piglets supplemented with scFOS support the view that scFOS positively impact piglet’s
health and resilience. However, the modes of action for these effects are not yet fully
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Background
During the last decades, pig selection has aimed at raising profitability by increasing litter size
[1]. Unfortunately this increasing litter size generally comes with a higher mortality. The high
mortality in these larger litters is attributed to the higher prevalence of low birth weight (LBW)
piglets [2–4]. At birth and around the time of weaning, changes in the diet, environment and
microbiome occur and the piglet’s gut has to rapidly adjust its digestive and immune functions
[5]. These processes are not optimally coordinated in case of a LBW and in consequence these
piglets have impaired gut functions even beyond weaning [5–10]. In addition, the LBW piglet
has difficulties getting access to sufficient colostrum and milk [3] and has a lower feed intake
after weaning [4, 11]. This poor milk and feed intake further aggravates their suboptimal gut
health contributing to the high preweaning [2, 3] and postweaning [4] mortality rates observed
in LBW piglets. Those LBW piglets that survive continue to have impaired gut functions [6–
10] with a higher risk to develop intestinal disorders and infections, and show long-lasting sub-
optimal growth performance [2, 11–15]. Nevertheless, the farmer has the opportunity for sup-
porting these piglets by either nutrition or management strategies, including a close
surveillance of these piglets to increase their colostrum and milk intake [4, 16, 17]. Due to the
aforementioned impact of gut health on resiliance and performance, optimizing and maintain-
ing gut health [5] should be key in chosing the intervention to improve performance and sur-
vival. Dietary non-digestible oligosaccharides have proven beneficial in this respect. The
health promoting effects of these oligosaccharides, such as fructo-oligosaccharides (FOS), are
attributed to a shift in the maternal microbiome transmitted to the neonate at birth and a
change in the immune and nutritional quality of the sow’s colostrum and milk in case of
maternal supplementation [18–21]. In case of FOS given to nursery piglets, a direct impact on
the microbiome is observed in addition to effects on the piglet’s intestinal morphology, gene
expression and immune system maturation [18, 19, 22–25]. It is suggested that the latter effects
on the immune system are mediated by a shift in the microbiota and the downstream effects of
the short-chain fatty acids (SCFAs) that are produced via fermentation of FOS [18, 19, 23, 26].
The aforementioned shift in the microbiome consist of promoting the growth of beneficial
bacteria while they are not used for the growth of potentially pathogenic bacteria, resulting in a
decrease in some potentially harmful bacteria as Clostridium perfringens, Clostridium difficile,
Escherichia coli or Streptococcus thermophiles, limiting their adhesion to the mucosa [27, 28].
In addition, some prebiotics can exert a direct antimicrobial effect, as they can adhere to the
binding sites of bacteria on the enterocyte surface and thus, block the adhesion of pathogenic
bacteria to intestinal epithelial cells [29, 30]. Next to promoting beneficial bacteria (i.e those
who promote body functioning and health such as Bifidobacterium and Lactobacillus), regular
supplementation with FOS leads also to the production of SCFA through fermentation of FOS
[18, 19, 23, 26]. These SCFA having important metabolic functions and play a crucial role in
intestinal health and immune cells [31, 32]. Indeed, microbiota-derived signals, including
SCFA, influence the crosstalk between epithelial cells and gut dendritic cells, thereby modulat-
ing the nature and intensity of intestinal B and T cell responses. By this way, it has been dem-
onstrated that FOS supplementation stimulated IgA secretion [33, 34], cytokine release
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(especially IFNγ) [33–35] and increased the numbers of natural killer cells and memory T cells
[35].
Short-chain fructo-oligosaccharides (scFOS) have a lower degree of polymerization (DP)
(DP between 3 and 5) when compared to the other FOS (DP 2–10) and inulin (DP 10–60). A
relevant number of publications clearly displays that the growth of beneficial bacteria differs
according to the type of prebiotic used, the growth being generally more effective and faster
with the smaller polymers like scFOS than longer chains as oligofructose and inulin [36, 37].
In vitro experiments of fermentation with faecal inoculum have also shown that scFOS are
more effective and quicker to stimulate SCFA production than long-chain prebiotics [38].
To our knowledge, the effects of short-chain fructo-oligosaccharides (scFOS) on the piglet’s
gut health and performance by supplementing scFOS to piglets exclusively during the suckling
period have not been investigated. Based on previous research using maternal and/or post-
weaning scFOS supplementation [18, 19, 22, 26], scFOS given to the suckling piglet is expected
to shape gut function and stimulate immune system maturation. This would improve the over-
all performance of these piglets resulting in increased weight gain and reduced mortality.
However it is not clear how long the piglet needs to be supplemented to experience these bene-
fits on gut health and performance. Therefore, two supplementation schemes were compared,
i.e. scFOS supplementation from birth until 7 days versus supplementation from birth until 21
days of age. The effects of this supplementation on piglet performance (until 2 weeks after
weaning), the piglet’s microbiome and various gut health parameters were studied in a field
trial comprising piglets of different birth weights (BiW): low, normal, high. We hypothesized
that 1) supplementation of scFOS improves gut microbiota, gut health and piglet’s perfor-
mance in the suckling and nursery phase depending on length of administration during suck-
ling, and 2) improvements are expected to especially benefit small piglets.
Methods
Animals, housing and experimental design
This experiment was approved by Ethics Committee of Faculty of Veterinary Medicine, Ghent
University under the ID EC2016/79. The study was performed at a local farm (Kalmthout, Bel-
gium). Seventeen sows from 2nd to 8th parity, with more than 14 live-born piglets (Hypor x
Pie´train) and that farrowed within a range of 2 days, were included. A total of 157 piglets were
selected at birth. Sows and piglets were housed in conventional farrowing units. During gesta-
tion, the sows were fed according to their body condition score and they received a standard
diet during both the gestation (Aveve nr. 9037, pellet, AVEVE N.V., Merksem, Belgium) and
lactation periods (Aveve nr. 9085, pellet, AVEVE N.V., Merksem, Belgium).
The day of the farrowing was set as d 0. After completion of the partus, all live-born piglets
in each litter were weighed and assigned to one of three BiW categories: high BiW (HBW,
BiW included within the upper quartile of the sample BiW), normal BiW (NBW, BiW between
75% and 25% of the sample BiW) and low BiW (LBW; (BiW included within the lower quar-
tile). At birth, the piglets in each litter were randomly assigned to one of the three different
treatments [control (CON), T1, and T2], considering BiW categories within the litter. This
way, a uniform distribution of the treatments across litters and BiW categories was assured
(p = 0.9). Mean (± SEM) weight per BiW category and treatment at the start of the experiment
can be found in Table 3, first row (d 0). The pigs of the control group (CON; n = 53, 29
females, 24 males) were drenched daily with 2 mL of solvent (lukewarm tap water) from d 0
until d 7, by means of a dosing pipet, enlarged with a 7-cm flexible tube (5 mm diameter). A
first treatment group (T1; n = 53, 28 females, 25 males) was drenched daily with 1 g of short-
chain fructo-oligosaccharides (scFOS, Profeed L95: total scFOS: 95g/100g, Beghin-Meiji,
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Tereos, Marckolsheim, France) (dose based on [18, 22, 26, 34] where weaned pigs were fed ad
libitum a diet supplemented with 0.15% scFOS equivalent to 1.2 g scFOS per pig per day)) dis-
solved in 2 mL solvent from d 0 until d 7. A second treatment group (T2; n = 51, 23 females, 28
males) was given 1 g scFOS (Profeed L95, Beghin-Meiji, Tereos, Marckolsheim, France) dis-
solved in 2 mL solvent from d 0 until weaning age (weaning age varied between 20 and 23 days
of age) (d 21.5: mean age at weaning).
All pigs were allowed to suckle the dam until weaning. In addition, pigs had free access to
supplementary milk (d 0 to d 7, Nuklospray1, Sloten, The Netherlands) and ad libitum creep
feed (d 7 to d 15, Aveve nr. 9204, meal; d 15 to weaning (d 21.5), Aveve nr. 9105, pellet,
AVEVE NV, Merksem, Belgie¨).
At weaning, pigs representing the 3 treatments and having a normal BiW (from 8 out of the
17 litters; 24 piglets, one of which died before the last sampling point) were transferred to a
separate nursery (Melle, Belgium), allocated in pairs (ensuring that piglets from the same treat-
ment and litter were housed together) in 2 m2 pens and raised under standard conditions until
sampling. Pigs were fed ad libitum and the ingredient and nutrient composition of the weaner
diet in the nursery is given in the S1 File. No antibiotics, ZnO or any other medicaments were
added to the feeds during the experimental period. These 20 pigs were euthanized at 2 weeks
post-weaning (see sampling section). The remaining 137 pigs (comprising pigs belonging to
the different BiW categories) were transferred to the nursery at the farm in Kalmthout. In the
nurseries, the room was ventilated via a conventional scheme, with a starting ambient temper-
ature of 30˚C that was gradually decreased to 28˚C at 15 d post-weaning. The light schedule
was 23 h of light and 1 h of dark during the first 5 d and 16 h of light and 8 h of dark (1900
until 0300 h) afterwards. Cage enrichment was provided following EC requirements.
Performance data (body weight, colostrum intake, fecal score, average daily gain, mortality)
were collected from the 137 pigs (comprising pigs belonging to the different BiW categories)
that remained at the farm (Kalmthout, Belgium). Pigs were weighed (no restriction to feed or
water) at d 0, d 1, d 2, d 7, d 21.5 (d 21,5 is used as the mean weaning age: piglets were weaned
between 20 and 23 days of age) and two weeks after weaning (at ages varying between 34 and
37 days of age (d 36.5: mean age 2 weeks post weaning)). At 24h, colostrum intake was esti-
mated using the formula of Theil et al. (2014) [39]. For different time periods, the average
daily gain (ADG, kg/d), was calculated. All pigs were checked daily for health issues and a fecal
score was given at pen level (Table 1). Mortality was reported as the percentage of dead pigs
(number of pigs that died / number of pigs included in the group at the day of birth).
Sampling
Fecal samples were taken from 8 pigs per treatment at d 7, d 21.5 and d 36.5. Fecal samples for
microbiome determination were snap frozen and stored at -80˚C pending further analysis.
Table 1. Fecal consistency scoring.
Score Description Interpretation
0 No feces Normal
1 Normal brown soft stool Normal
2 Yellow or dark black (bloody) soft formed sticky feces Indication of diarrhea
3� Watery, stool or yellow or dark black (bloody) diarrhea. Diarrhea
4 All piglets of a litter have score 3 Severe diarrhea
�In case of score 3, the number of piglets showing wet backsides (indicative for diarrhea) will be counted.
https://doi.org/10.1371/journal.pone.0233910.t001
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Fecal samples pending determination of short-chain fatty acids (SCFAs) were acidified with
2% (ratio H2SO4/feces volume) of a 6MH2SO4 solution, prior to storage at -20˚C.
At d 36.5 (2 weeks post-weaning), the 20 pigs (CON: n = 7, 3 females, 4 males; T1: n = 8, 5
females, 3 males; T2: n = 8, 2 female, 6 males) that were transferred to the seperate nursery (see
above), were euthanized by an overdose of intraperitoneal Na-pentobarbiturate (90 mg/kg)
followed by exsanguination after which blood, digesta and tissue samples were collected.
Serum samples were allowed to clot for 20 min at room temperature. Plasma samples were
collected in EDTA-tubes. Both samples were centrifuged at 4˚C at 3,000 g for 10 min and
stored at -20˚C pending analysis for IgG and calprotectin.
Immediately after the pigs were euthanized, the abdomen was opened, the gastrointestinal
tract was removed and the lengths of the small and large intestine recorded. The small intestine
was equally divided into a proximal, middle and distal part and 5-cm segments were collected
and flushed with saline. Two segments were immediately frozen in liquid nitrogen and stored
at -80˚C and two segments were fixated in 4% paraformaldehyde solution (0.1 M, pH 7.4) at
room temperature for 2 h. Samples for next generation sequencing were taken from the differ-
ent small intestinal regions, where 10 cm segments were flushed, the mucosa scraped, col-
lected, transferred to vials and immediately immersed in liquid N2 and stored at -80˚C
pending further analysis. A small intestinal segment of approximately 20 cm was collected
proximal to 75% of the total small intestinal length and immediately transferred to the Ussing
chamber set-up to measure mucosal permeability.
Digesta pending determination of short-chain fatty acids (SCFAs) were collected from the
most caudal 10% of the small intestine and from a 20-cm section distal to 50% of the total
colon length. Samples were acidified with 2% of a 6 M H2SO4 solution, prior to storage at
-20˚C.
Analysis of feces
Fecal samples were used for microbiome analysis, metabolic profiling (SCFAs analysis) and
calprotectin measurement.
Out of the fecal samples collected at d 7, d 21.5 and d 36.5, DNA was extracted using the
PowerFecal DNA-extraction kit (Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. DNA samples were quantified using a Qubit 3.0 Fluorometer (Thermo Fisher Sci-
entific, Waltham, USA). Subsequent 16S rRNA sequencing was performed as described by
Kozich et al. (2013) [40]. In summary, PCR amplicons resulting from a barcoded PCR assay
were cleaned and equimolary pooled using the SequalPrep normalization kit (Invitrogen, Life
Technologies, Grand Island, USA). The pooled amplicon library was loaded on a 0.8% agarose
gel after which the amplicons were cut out and purified with the NucleoSpin gel and PCR
clean-up kit (Macherey-Nagel, Du¨ren, Germany). The final library was denatured with 0.2 N
NaOH, diluted to 7 pM, spiked with 10% PhiX control DNA (Illumina, San Diego, USA) and
subsequently sequenced using 2 x 250 cycles on the Illumina MiSeq sequencer. Sequences
were processed using the DADA2 package, following the DADA2 standard operation protocol
[41]. Sequences were classified using RDp version 14 [42] and the resulting sequence and tax-
onomy table were imported in to the Phyloseq package v1.18.1 [43] to calculate alpha and beta
diversity and plotting of taxonomic profiles as described previously [44].
Fecal samples collected at d 36.5 were used for SCFA’s analysis and calprotectin measure-
ments. To 1 g of sample, 5 mL 10% formic acid solution with 1 mg/mL 2-ethylbutyric acid as
internal standard was added, vortexed and centrifuged at 1,200 g for 5 min. After filtration, the
supernatant was injected for gas chromatographic separation to determine SCFA’s [45]. Fecal
calprotectin levels were determined using a (human) calprotectin ELISA kit (CALPROLAB
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Calprotectin ELISA (ALP), CALPRO AS, Lysaker, Norway). Sample preparation was per-
formed using a lower dilution factor than recommended in manufacturer’s guidelines, as cal-
protectin levels are expected to be lower in pigs than in human babies [46]. Briefly, fecal
samples were thawed and 50 mg of feces were transferred to a 2 mL Eppendorf tube and sus-
pended in 995 μl of extraction buffer (weight:volume ratio 1:20). Samples were sonicated (5
cycles of a 5 s pulse followed by 10 s off) on ice, subsequently put on a shaker for 30 min at 400
rpm, quick-spun down and the supernatants analyzed. All the samples, standards and controls
were assayed in duplicate and expressed as μg/g feces.
Analysis of blood samples
Plasma IgG content and calprotectin contents were determined using an IgG ELISA kit (Pig
IgG ELISA kit, Alpha Diagnostic Intl., Texas, USA) and a calprotectin ELISA kit (CALPRO-
LAB Calprotectin ELISA (ALP), CALPRO AS, Lysaker, Norway), respectively. Both kits were
used according to the manufacturer’s instructions. No dilution was carried out in plasma sam-
ples prior to the calprotectin assay, whereas a final dilution of 1:100,000 was applied for the the
IgG Elisa kit. All the samples, standards and controls were assayed in duplicate. The concentra-
tions of IgG and calprotectin were expressed as ng/mL serum.
Analysis of digesta
Lactic acid was assessed in microdiffusion cells following Conway [47] and expressed as μM/g
of fresh matter. The concentrations of SCFAs (acetate, butyrate, isobutyrate, proprionate, vale-
ric acid and isovaleric acid) were determined by using gas chromatography according to the
method used for the metabolic profiling of feces (see above) and described by Jin et al. 2017
[45]. The total and the individual SCFA concentrations in digesta were expressed as μM/g of
fresh matter.
Mucosal permeability
Intestinal mucosal permeability was assessed ex vivo by measuring the translocation of macro-
molecular markers using the Ussing chamber technique. The 20-cm segments of the distal
small intestine were rinsed with saline. The mucosal layer was stripped from the seromuscular
layer and pinned onto 1.07 cm2 sliders that were mounted into Ussing chambers (Muβler Sci-
entific Instruments, Aachen, Germany). Tissues were immersed in 6.5 mL Ringer solution
(115 mM NaCl, 5 mM KCl, 25 mM NaHCO3, 2.4 mM Na2HPO4, 0.4 mM NaH2PO4, 1.25 mM
CaCl2, 1 mM MgSO4) with 6 mM of mannitol or glucose in the luminal and serosal side,
respectively. The system was water-jacketed to 37˚C and oxygenated with 95% O2 and 5%
CO2. After an equilibration period of 20 min, 4 kDa fluorescein isothiocyanate-dextran (FD-4,
Sigma-Aldrich, Bornem, Belgium) was added to the luminal side to a final concentration of 0.8
mg/mL. Samples of the buffer solution were taken from the serosal chamber at 20, 40, 60 and
100 min after adding FD-4. Fluorescence intensity of FD-4 in the medium was measured at
excitation wavelength of 485 nm and emission wavelength of 538 nm using a fluorescence
plate reader (Thermo Scientific, Marietta, USA). The apparent permeation coefficient (Papp)
was calculated as:
Papp (cm/s) = (dc/dt) × V/c0/A, where dc/dt is the change in the marker (FD-4) concentra-
tion at the serosal side (acceptor) between 20 and 100 min, (μg • mL-1 • s-1) calculated from the
slope of the concentration–time curve, V is the buffer volume in the luminal side (donor) of
the compartment (mL), C0 is the initial marker concentration in the donor compartment (μg •
mL-1) and A is the exposed tissue surface area (cm2).
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Immunohistochemistry for tight junction proteins
Immunohistochemistry of the most relevant tight junction proteins [occludin (OCLN), zona
occludens-1 (ZO-1) and claudin-2 (CLDN-2)] was performed on 4-μm, paraffin sections from
the small intestine and the colon. Antigen retrieval was carried out for OCLN and ZO-1 by
incubating with proteinase K (Dako; Glostrup, Denmark) for 1 min at 37˚C. Then, the sections
were incubated with 3% H2O2 dissolved in methanol, for 30 min and subsequently incubated
with 10% (CLDN-2) or 20% (OCLN and ZO-1) normal goat serum (Jackson Immunoresearch
Inc, West Grove, USA) dissolved in Tris-buffered saline (TBS) (0.01 M Tris, pH 7.4) for 30
min at room temperature. Subsequently, sections were incubated overnight at 4˚C with poly-
clonal rabbit anti-OCLN (1/75, Invitrogen, Camarillo, USA), rabbit anti-ZO-1 (1/100 Santa
Cruz Biotechnology Inc., Texas, USA), or rabbit anti-CLDN-2 antibody (1/50, Invitrogen,
Camarillo, USA). All primary antibodies were diluted in TBS enriched with 0.3% Triton-X-
100 (Sigma-Aldrich, Bornem, Belgium). After washing in TBS, sections were incubated with
biotinylated goat anti-rabbit antibody (1/200 diluted in TBS enriched with 0.3% Triton-X-100
and 1% bovine serum albumin (BSA; ThermoFisher Scientific, Waltham, USA) for 30 min at
room temperature. Following rinsing with TBS, sections were incubated for 30 min with strep-
tavidin-conjugated horseradish peroxidase (sHRP) (1/200 diluted in TBS enriched with 0.3%
Triton-X-100 and 1% BSA) (Agilent, Santa Clara, USA) at room temperature. After rinsing
with TBS and demineralized water, tight junction proteins were visualized with 3,3’-diamino-
benzidinetetrahydrochloride (Sigma-Aldrich, Bornem, Belgium). The presence of the different
tight junction proteins was evaluated considering the number of positively stained sections,
presence of staining in the crypts, base of the villus, mid villus and tip of the villus.
Histomorphology
After deparaffinization, 4-μm sections were conventionally stained with haematoxylin-eosin
(HE). The morphometric measurements [villus height, crypt depth, and number of intra-epi-
thelial lymphocytes (IEL) per μm villus height (small intestine) or crypt depth (colon)] were
performed on at least 15 sections per animal which resulted in measuring 30 longitudinally cut
villi and their adjacent crypts (Olympus BX 61, analySIS Pro, Aartselaar, Belgium).
Western blot analysis for regeneration capacity
Frozen samples of the proximal small intestinal region were homogenized in lysis buffer (50
mM Tris, 150 mM NaCl, 1% Nonidet P40 (vol/vol), 0.5% deoxycholate (wt/vol)) comple-
mented with a complete protease inhibitor cocktail tablet (Roche Applied Science, Mannheim,
Germany). Protein extracts (10 μg) were resolved by Mini protean TGX 4% to 15% gradient
gels (Bio-Rad Laboratories, Hercules, USA) and transferred to a nitrocellulose membrane
(Bio-Rad Laboratories, Hercules, USA). After blocking nonspecific protein binding with 5%
nonfat dry milk in Tris buffer (10 mM Tris, 150 mM NaCl, 0.05% Tween-20, pH 7.6) for 1 h,
blots were probed with anti-Proliferating Cell Nuclear Antigen (anti-PCNA) (1:5,000 in Tris
buffer, Dakocytomation, Glostrup, Denmark) or anti-caspase-3 (1:1,000 in Tris buffer, Sigma-
Aldrich, Bornem, Belgium). Subsequently, secondary antibodies were applied at room temper-
ature: for PCNA a sHRP-conjugated goat anti-mouse antibody (1:5,000 in Tris buffer, Dakocy-
tomation, Glostrup, Denmark) and for caspase-3, a sHRP-conjugated goat anti-rabbit
antibody (1:1,000 in Tris Buffer, Dakocytomation, Glostrup, Denmark) was applied. Detection
of a positive immunoreaction was performed using a chemiluminescence system (SuperSignal
West Femto Maximum Sensitivity Substrate, Thermo Scientific, Rockford, Illinois, USA). Pro-
tein band intensities were quantified using densitometry (GeneSnap and GeneTools software,
Syngene, Cambridge, UK). A normalized optical density (OD) was obtained by dividing the
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protein density by the density of the loading control β-actin (Sigma-Aldrich, Steinheim,
Germany).
Real time qPCR
RT-qPCR (MUC2, IL1β, IL6, TNFα, INFγ, IL10) was performed according to the MIQE guide-
lines [48]. In brief, mucosal total RNA was extracted using the Bio-Rad Aurum Total RNA
Fatty and Fibrous Tissue Kit (Bio-Rad Laboratories, Inc., Hercules, USA) according to the
manufacturer’s instructions, including an on-column DNase I treatment to remove genomic
DNA (gDNA). The concentration and purity (OD260/280) of RNA were measured with the
NanoDrop ND-1000 (NanoDrop Technologies, Thermo Scientific, Wilmington, USA).
One μg RNA was analyzed by 1% agarose gel electrophoresis to check RNA integrity (28S and
18S rRNA bands). In addition, a minus-RT control PCR was performed using YWHAZ as
primer to verify the absence of any gDNA contamination. Following this, 1 μg of high quality
DNA-free RNA was reverse transcribed in the 20 μL reverse-transcription reaction with the
ImProm-II cDNA synthesis kit (Promega, Madison, USA), containing both oligo dT and ran-
dom primers. The obtained cDNA was diluted 10 times with molecular grade water and a con-
trol PCR using 2μL cDNA was performed to verify the reverse-transcription reaction.
Primers (Table 2) used for genes in the study were designed with Primer3Plus. The repeats,
the secondary structure and single nucleotide polymorphism in the target sequence were
checked with RepeatMarker, mfold and dbSNP, respectively. All these primer sequences were
gene isoform specific as they were designed based on certain exon-exon boundaries of pub-
lished pig gene sequences corresponding to the accession number. Primers were then pur-
chased from IDT (Integrated DNA Technologies, Leuven, Belgium).
The RT-qPCR was carried out on the CFX96 Touch Real-Time PCR Detection System
(Bio-Rad Laboratories, Inc.). Briefly, 2μL cDNA template, 5 μL 2X KAPA SYBR FAST qPCR
Kit Master Mix (Kapa Biosystems, Inc., Wilmington, USA), 2 μL molecular grade water, 0.5 μL
forward primer and 0.5 μL reverse primer (5 μM each) were added to a total volume of 10 μL.
The amplification conditions were as follows: 1) enzyme activation and initial denaturation
(95˚C for 3 min); 2) denaturation (95˚C for 20 s) and annealing/extension and data acquisition
(annealing temperature depending on primer for 40 s) repeated 40 cycles; and 3) dissociation
(melt curve analysis from 70 to 90˚C with 0.5˚C increment every 5 s).
Table 2. Primer sequences used for reverse-transcription quantitative real-time PCR.
Gene symbol1 Accession number Nucleotide sequence of primers, 5’-3’ Product length (bp) Ta ˚C
Forward Reverse
MUC2 XM_013989745 AGGACGACACCATCTACCTCACTC GGCCAGCTCGGGAATAGACCTT 132 58
IL-1β NM_214055.1 GCACCCAAAACCTGGACCT CTGGGAGGAGGGATTCTTCA 143 58
IL-6 NM_214399.1 AGCCCACCAGGAACGAAAGAGAG GGCAGTAGCCATCACCAGAAGCA 165 58
TNF-α NM_214022.1 CATGATCCGAGACGTGGAGC AACCTCGAAGTGCAGTAGGC 151 62
IFN-γ NM_213948.1 GCTTTTCAGCTTTGCGTGACT CACTCTCCTCTTTCCAATTCTTCA 166 58
IL-10 XM_013979620.1 GAAGACGTAATGCCGAAGGC GCTGGTCTGCTACTCACACAG 122 62
TLR-4 NM_001113039.2 TTCTTGCAGTGGGTCAAGGA GACGGCCTCGCTTATCTGAC 135 58
IAP XM_003133729.3 GGCCAACTACCAGACCATCG CCGACTTCCCTGCTTTCTTG 116 60
ACTß XM_003124280.3 TCTGGCACCACACCTTCT TGATCTGGGTCATCTTCTCAC 114 60
TBP DQ178129 GATGGACGTTCGGTTTAGG AGCAGCACAGTACGAGCAA 124 59
TOP2ß NM_001258386.1 AACTGGATGATGCTAATGATGCT TGGAAAAACTCCGTATCTGTCTC 137 60
1MUC2: mucin 2; IL-1β: interleukin 1 beta; IL-6: interleukin 6; TNF-α: tumor necrosis factor alpha; IFNγ: interferon gamma; IL-10: interleukin 10; TLR-4: toll-like
receptor-4; IAP: intestinal alkaline phosphatase; ACTß: actin beta; TBP: TATA-binding protein; TOP2ß: DNA topoisomerase II beta.
https://doi.org/10.1371/journal.pone.0233910.t002
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The primers used in this study were first optimized by gradient quantitative real-time PCR.
A 5-fold dilution series (5 points, from 1 to 625 times dilution) of cDNA as a standard curve
was included at 3 gradient temperatures to determine PCR amplification efficiency and speci-
ficity. The standard curve was also included in each run to determine PCR efficiency. In this
study, PCR amplification efficiencies were consistently between 90 and 110%. Gene-specific
amplification was verified by agarose gel electrophoresis and melting curve analysis. Efficiency
was used to convert the Cq value into raw data with the highest expressed samples (lowest Cq
value) as a calibrator for the normalization of raw data. The relative expression was expressed
as a ratio of the target gene to the geometric mean of 3 stable expressed reference genes
(ACTB, TOP2B and TBP) [45, 49].
Statistical analysis
The data from the piglets that remained at the farm were used for the analysis of performance
parameters. For the fecal samples and the parameters determined using samples of piglets
euthanized at d 15 post-weaning the data were not split up according to the BiW category
since only NBW piglets were used.
Linear mixed models were fitted to evaluate the effect of treatment, age and BiW (perfor-
mance data only) on the outcome variables (JMP pro 13.0). Fixed factors included treatment,
age, BiW (performance data only) and the interaction between the different fixed factors. To
account for the dependence between the observations on littermates, sow was included as a
random factor. For the different measurements of body weight on the same pigs at different
ages, piglet nested in sow was added as a random factor. Additionally, a random slope for age
vs piglet nested in sow was checked. For the analysis of the digesta and the morphology sam-
ples that were collected at the level of the small and large intestine at the time of euthanasia,
the fixed factor for age was replaced by sampling site (small vs large intestine) and the random
slope sampling site vs piglet nested in sow was checked. The starting model was simplified
using stepwise backwards modelling.
Alpha level used for significance determination� 0.05. Post-hoc analysis with Tukey’s cor-
rection was used for the comparison of different treatments, ages and BiW categories. The
fecal score was analyzed with the Chi Square test. Mortality rates between the sexes, BiW cate-
gories and treatments were analyzed via the non-parametric Kaplan-Meier method and post-
hoc analysis was carried out via pair-wise comparisons using the Wilcoxon Rank test. Differ-
ences in alpha diversity of the gut microbiota were assessed using the Wilcoxon Rank test,
while a t-test was used to estimate differences in mean relative abundance. Fecal calprotectin
levels, lactic acid and proprionate levels in the digesta, and MUC2 and IL-6 mRNA ratios were
analyzed using the non-parametric Wilcoxon Rank test. Data on small intestine length, relative
to BW small intestinal length, total SCFA’s and butyrate in digesta, Papp of FD-4, number of
IEL per μm villus or crypt, and IAP, IL-10, IFNγ mRNA ratios were log-transformed to meet
normality and/or homoscedasticity assumptions. The piglet is considered the experimental
unit. All data are presented as means ± SEM.
Results
Growth performance, colostrum intake and mortality
There was no effect on body weight between males and females (p = 0.7), and no interaction
effect between sex and treatment (p = 0.4), sex and age (p = 0.4) and sex and BiW (p = 0.6).
There was no interaction effect between treatment and age (p = 0.062) regarding body weight
(Table 3). There was a significant interaction effect on body weight between age and BiW
(p< 0.001). Therefore, differences in body weight between the six time-points (d 0, d 1, d 2, d
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7, d 21.5, d 36.5) were analyzed within each BiW and the difference between the BiW was
checked within each time point. In each BiW, body weight started to significantly increase
after two days of life (LBW: p< 0.001; NBW: p = 0.008; HBW: p< 0.001) (Table 3). Addition-
ally, at each time instance, the body weight of LBW was significantly lower than that of NBW
and HBW (for all post-hoc comparisons). Yet, piglets belonging to NBW and HBW reached
comparable body weights at 2 weeks post-weaning (p = 0.1) (Table 3).
Finally, we found an interaction effect between treatment, age and BiW (p< 0.001)
(Table 3). This means that any effect of scFOS supplementation on body weight differs
between ages and BiW. Thus, in order to facilitate the understanding of our results, we looked
at the interaction treatment and age in the different BiW categories. There was no significant
effect in LBW and HBW piglets (p = 0.2 and p = 0.9, respectively). However, in NBW, the pig-
lets supplemented lukewarm water (CON) and those supplemented scFOS for 7 days (T1) had
lower body weights compared with those supplemented scFOS for 21 days (T2) at weaning
and at the end of the experiment (p< 0.001 for the interaction effect) (Table 3). Alternatively,
the interaction effect between treatment and BiW could mean that differences in body weight
between piglets having other BiWs are not the same within each treatment group. This was not
the case since post-hoc analysis revealed that in each of the treatment groups (CON: p< 0.001,
T1: p< 0.001; T2: p< 0.001), the body weight of the LBW stayed below that of the NBW and
HBW and that the body weight of NBW stayed below that of HBW (all post-hoc comparisons
p< 0.001).
Regarding colostrum intake, no interaction effects were observed between sex and BiW
(p = 0.2), between sex and treatment (p = 0.7) and between treatment and BiW (p = 0.9). As
expected, sex (p = 0.4) (female: 326.8 ± 6.4 g; male: 326.6 ± 6.7 g) and treatment (p = 0.4)
(CON: 325.6 ± 8.0 g; T1: 324.2 ± 7.7 g; T2: 330.5 ± 8.4 g) did not affect colostrum intake
Table 3. Body weight (BW; kg; mean ± SEM) in relation to supplementation with scFOS, age and birth weight category.
BW, kg LBW1 NBW1 HBW1
CON2 T12 T22 CON2 T12 T22 CON2 T12 T22
(n = 13) (n = 12) (n = 11) (n = 21) (n = 23) (n = 21) (n = 13) (n = 11) (n = 12)
d 0 1.02 ± 0.02a - x 1.35 ± 0.01a -y 1.69 ± 0.02a-z
1.02 ± 0.04 1.02 ± 0.03 1.03 ± 0.03 1.35 ± 0.03 1.35 ± 0.02 1.37 ± 0.03 1.68 ± 0.03 1.67 ± 0.02 1.72 ± 0.03
d 1 1.07 ± 0.02a - x 1.43 ± 0.02a -y 1.75 ± 0.02a - z
1.08 ± 0.04 1.07 ± 0.03 1.06 ± 0.04 1.44 ± 0.03 1.40 ± 0.03 1.45 ± 0.03 1.75 ± 0.03 1.72 ± 0.03 1.77 ± 0.05
d 2 1.13 ± 0.03a - x 1.53 ± 0.02a -y 1.86 ± 0.03a - z
1.14 ± 0.06 1.14 ± 0.04 1.10 ± 0.05 1.53 ± 0.04 1.50 ± 0.04 1.56 ± 0.04 1.87 ± 0.05 1.85 ± 0.06 1.86 ± 0.06
d 7 1.68 ± 0.07b – x 2.26 ± 0.06b - y 2.71 ± 0.07b - z
1.58 ± 0.14 1.76 ± 0.12 1.71 ± 0.13 2.16 ± 0.11 2.15 ± 0.09 2.47 ± 0.11 2.79 ± 0.11 2.67 ± 0.16 2.67 ± 0.11
d 21.53 4.52 ± 0.23c - x 5.61 ± 0.19c - y 6.26 ± 0.18c – z
4.25 ± 0.58 4.71 ± 0.31 4.57 ± 0.40 5.03 ± 0.41 5.37 ± 0.27 6.36 ± 0.23 6.10 ± 0.36 6.59 ± 0.23 6.16 ± 0.27
d 36.54 6.62 ± 0.23d - x 8.36 ± 0.20d – y 8.74 ± 0.22d - y
6.99 ± 0.31 6.99 ± 0.37 5.95 ± 0.35 7.99 ± 0.46 7.96 ± 0.30 8.98 ± 0.29 8.69 ± 0.36 8.97 ± 0.23 8.59 ± 0.48
1Birth weight categories (LBW: low birth weight; NBW: normal birth weight; HBW: high birth weights)
2Treatments: CON = Piglets drenched with 2 mL tap water until d 7; T1 = Piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-
Meiji) dissolved in 2 mL tap water until d 7; T2 = Piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age)
3End suckling period
42 weeks post-weaning
a-dDifferent superscripts within a column (birth weight category) indicate significantly different body weights between the time instants (p < 0.05).
x-z Different superscripts within a row (time instants) indicate significantly different body weights between the birth weight categories (p < 0.05).
https://doi.org/10.1371/journal.pone.0233910.t003
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whereas BiW significantly did (p< 0.001). Colostrum intake was lowest in LBW (258.5 ± 3.6
g), intermediate in NBW (325.5 ± 3.0 g) and highest in HBW (391.5 ± 3.2 g) (for all post-hoc
comparisons p< 0.001).
ADG, determined at the end of three different periods, was not affected by interaction
effects between sex and BiW (d 0 to d 7: p = 0.3; suckling period: p = 0.087; 2 weeks post-wean-
ing: p = 0.6), between sex and treatment (d 0 to d 7: p = 0.5; suckling period: p = 0.4; 2 weeks
post-weaning: p = 0.6) nor between treatment and BiW (d 0 to d 7: p = 0.2; suckling period:
p = 0.1; 2 weeks post-weaning: p = 0.3). Sex did not affect the ADG during the suckling period
(d 0 to d 7: p = 0.2; female: 115.0 ± 6.8 g; male: 135.9 ± 8.6 g) (suckling period: p = 0.2; female:
187.3 ± 7.8; male: 205.6 ± 8.2 g) and during the 2 weeks post-weaning (p = 0.4; female:
150.5 ± 8.5 g; male: 143.2 ± 6.8 g). In addition, the ADG of the piglets was not affected by
drenching scFOS (d 0 to d 7: p = 0.7; suckling period: p = 0.3; 2 weeks post-weaning: p = 0.2)
(Table 4). However, ADG significantly differed when comparing piglets belonging to different
BiW during the suckling period (d 0 to d 7: p< 0.001; suckling period: p < 0.001; 2 weeks
post-weaning: p = 0.1). Throughout the suckling period, LBW gained less weight when com-
pared with NBW and HBW (Table 4).
No clear signs of diarrhea (overall fecal score 1.72 ± 0.05, which is considered normal) were
observed throughout the experimental period but differences were observed when comparing
the fecal scores for the different BiW (p = 0.036). The mean fecal score of LBW (1.81 ± 0.08;
p = 0.022) as well as HBW (1.74 ± 0.1; p = 0.042) were slightly higher when compared with
NBW (1.67 ± 0.06). Drenching with scFOS did not affect the fecal score (CON = 1.71± 0.18;
T1 = 1.84± 0.16; T2 = 1.60 ± 0.22; p = 0.9). There was no interaction between BiW and scFOS
drenching (p = 0.5).
The mortality rate was similar between sexes (p = 0.8; female: 20.8%, male: 21.5%). As
expected, the overall mortality rate differed between the piglets with differing BiW (p = 0.048)
where the mortality rate was lowest in HBW (8.3%) compared to NBW (24.2%) and LBW
(30.6%). It needs to be noted that the average mortality rate in the farrowing unit at the farm
was high during the experiment (16.5%). Given mortality in the first weeks after birth is mostly
attributed to the starvation-crushing-hypothermia complex [3], and no treatment effect was
observed on the pre-weaning mortality rates (when looking at overall treatment affect and
treatment effect by BiW category), we focused on post-weaning mortality rates to discern a
Table 4. Average daily gain (ADG) (g per day; mean ± SEM) at different ages and for different birth weight category and supplemented or not with scFOS.
ADG, g/d LBW1 NBW1 HBW1
CON2 T12 T22 CON2 T12 T22 CON2 T12 T22
(n = 13) (n = 12) (n = 11) (n = 11) (n = 23) (n = 21) (n = 13) (n = 11) (n = 12)
d 0–7 95.2 ± 9.4a 127.9 ± 8.1b 145.3 ± 9.7c
81.8 ± 19.2 105.6 ± 15.6 98.4 ± 13.8 116.1 ± 13.9 114.1 ± 10.5 154.3 ± 16.3 157.1 ± 14.2 141.4 ± 23.2 135.2 ± 14.3
d 0–21.53 167.2 ± 11.7a 198.3 ± 8.8b 213.5 ± 8.3c
154.3 ± 29.0 176.4 ± 16.9 168.5 ± 17.0 172.0 ± 19.8 186.1 ± 12.2 233.8 ± 10.2 207.9 ± 16.8 229.3 ± 11.3 206.9 ± 12.7
d 21.5–36.54 116.7 ± 9.2 157.2 ± 7.1 155.0 ± 11.4
119.2 ± 8.8 142.7 ± 8.9 86.2 ± 18.9 148.9 ± 18.3 156.4 ± 10.2 163.5 ± 10.7 161.9 ± 12.5 148.9 ± 19.5 152.1 ± 27.4
1Birth weight categories (LBW: low birth weight; NBW: normal birth weight; HBW: high birth weight).
2CON = Piglets drenched with 2 mL tap water until d 7; T1 = Piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-Meiji)
dissolved in 2 mL tap water until d 7; T2 = Piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age)
3Suckling period
4Post-weaning period
a-cDifferent superscripts within a row (time instants) indicate a significantly different ADG between the birth weight categories (p < 0.05).
https://doi.org/10.1371/journal.pone.0233910.t004
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possible effect of treatment. In contrast to sex (p = 0.3; female: 8.1%; male: 3.8%) and BiW
(p = 0.2; LBW: 7.4%; NBW: 9.6%; HBW: 0.0%), treatment had a significant effect on the post-
weaning mortality rates (p = 0.025). Post-hoc analysis revealed that the post-weaning mortality
rate was significantly lower in T2 (0.0%, p = 0.018), and numerically lower in T1 (2.6%,
p = 0.082), when compared with the piglets that were not supplemented (CON: 13.9%) (Fig 1).
Moreover, we investigated the effect of the treatment in each individual BiW category. In this
regard, we did not observe any difference in heavy piglets (post-weaning mortality was 0% in
all treatments), but we observed a trend in LBW piglets (two animals belonging to the CON
group died, while there was no mortality in T1 and T2 groups; p = 0.072). A significant differ-
ence was observed in NBW piglets, with four out of the five deaths reported in the CON piglets
and one out of five being in the T1 group; p = 0.027).
Microbiota
The alpha-diversity of the gut microbiota was not affected by the supplementation of scFOS
(all comparisons p> 0.05; Fig 2A). However, the mean relative abundance of the main micro-
bial species differed between the samples collected at different time points (d 7, d 21.5 and d
36.5) (Fig 2B). Fecal samples collected at d 7 were characterized by a relative high abundance
of Bacteroides (d 7 vs d 36.5; CON: p< 0.001; T1: p = 0.004; T2: p = 0.004) and Escherichia (d
7 vs d 36.5; CON: p = 0.02; T1: p = 0.03; T2: p = 0.02) whereas at 2 weeks post-weaning (d
36.5) Prevotella (d 7 vs d 36.5; CON: p = 0.001; T1: p = 0.06; T2: p = 0.005) predominated over
other species. The relative abundance of Lactobacillus spp. (d 7 vs d 36.5; CON: p = 0.2; T1:
p = 0.04; T2: p = 0.04) decreased over time. Bifidobacteriaceae were only detected in a few
samples.
Fig 1. Post-weaning mortality rate according to treatment (black bars) and according to birth weight category x treatment
(white bars). LBW (piglets with a birth weight in the lower quartile of the birth weight ranges), NBW (between 75% and 25%)
and HBW category high (lower quartile) birth weight categories. CON represents piglets drenched with 2 mL tap water until d 7
(n = 13 (HBW), n = 21 (NBW) and n = 13 (LBW)); T1 represents piglets drenched with 1 g short-chain fructo-oligosaccharides
(scFOS, Profeed P95, Beghin-Meiji) dissolved in 2 mL tap water until d 7((n = 12 (HBW), n = 23 (NBW) and n = 11 (LBW)) and
T2 represents piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age) (n = 11 (HBW), n = 21
(NBW) and n = 12 (LBW)).
https://doi.org/10.1371/journal.pone.0233910.g001
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In general, no effect of scFOS treatment on the mean relative abundance was found (all
comparisons p> 0.05). However, compared to the control group, the mean relative abundance
Fig 2. Alpha diversity (panel A) and the taxonomic profiles (panel B) of the microbiome determined in feces collected at d 7, d 21.5 and d
36.5 of life in CON (piglets drenched with 2 mL tap water until d 7) (n = 7); T1 (piglets drenched with 1 g short-chain fructo-
oligosaccharides (scFOS, Profeed P95, Beghin-Meiji) dissolved in 2 mL tap water until d 7) (n = 8) and T2 (piglets drenched with 1 g
scFOS dissolved in 2 mL tap water until d 21.5 (weaning age)) (n = 8). No differences were observed between the different treatment
groups.
https://doi.org/10.1371/journal.pone.0233910.g002
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of Bacteroides was found to be temporarily reduced by scFOS supplementation in the first
week of life in the T1 group only (p = 0.049; Fig 2B). Furthermore, a higher mean relative
abundance for Lachnoclostridium was found at d 21.5 in the T2 group (p = 0.03; Fig 2B).
Metabolic profiling: Analysis of short-chain fatty acids in fecal and digesta
samples
Short-chain fatty acids were quantified in 24 fecal samples taken at d 7, d 21.5 and d 36.5 (Fig
3). The total concentration of SCFAs was unaffected by drenching of scFOS (p = 0.2) but dif-
fered significantly when comparing different ages (p < 0.001). In this regard, the total concen-
tration of SCFAs was significantly higher after weaning when compared with the levels seen
during the suckling period (8.75 ± 0.67, 8.99 ± 0.54 and 23.00 ± 1.19 μM/g feces on d 7, d 21.5,
and d 36.5, respectively; p< 0.001). A similar observation was made for the individual SCFAs:
acetate, proprionate, butyrate and valerate (Fig 3). None of the levels of these SCFAs differed
between the treatment groups (acetate p = 0.5; proprionate p = 0.7; butyrate p = 0.3; valerate
p = 0.8) and all of them reached higher concentrations 2 weeks post-weaning when compared
to the values seen at day 7 and 21 (for all SCFAs p< 0.001). In addition to these changes with
age, butyrate and valerate dropped to half of their levels in the feces of 1-week old piglets
(p< 0.001) at the end of the suckling period (d 21.5) to then reach higher values at the end of
the experiment. The concentration of the branched SCFAs isovalerate and isobutyrate, which
Fig 3. Concentration (μM) of short chain fatty acids (SCFA) per g feces at d 7, d 21.5 and d 36.5 of life: Acetate (dotted),
proprionate (dashed), butyrate (white), valerate (double dashed), isovalarate (gray) and isobutyrate (black). CON represents
piglets drenched with 2 mL tap water until d 7 (n = 7); T1 represents piglets drenched with 1 g short-chain fructo-oligosaccharides
(scFOS, Profeed P95, Beghin-Meiji) dissolved in 2 mL tap water until d 7 (n = 8) and T2 represents piglets drenched with 1 g
scFOS dissolved in 2 mL tap water until d 21.5 (weaning age) (n = 8). No differences were observed between the different
treatment groups. The concentration of the total SCFAs and its major constituents (acetate, proprionate, butyrate and valerate)
was significantly higher after weaning. The concentrations of butyrate and valerate showed a dip at the end of the suckling period
(d 21.5).
https://doi.org/10.1371/journal.pone.0233910.g003
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are break-down products of amino acids rather than carbohydrates, were not affect by the
treatment (isovalerate p = 0.5; isobutyrate p = 0.4). In contrast to the other SCFAs their levels
remained constant throughout the experiment (isovalerate p = 0.3; isobutyrate p = 0.2).
Short-chain fatty acids were also analysed in digesta samples, which were collected from the
distal small intestine and mid colon at the end of the experimental period (d 36.5) (Table 5).
Treatment did not affect the total concentrations of SCFAs (small intestine p = 0.7; colon
p = 0.8) nor that of the individual SCFAs (small intestine: acetate p = 0.8; proprionate p = 0.8;
butyrate p = 0.9; mid colon: acetate p = 0.5; proprionate p = 0.9; butyrate p = 0.2; valerate
p = 0.9), short-branched SCFAs (mid colon: isovalerate p = 0.6; isobutyrate p = 0.3) and
lactic acid (small intestine: p = 0.4; mid colon p = 0.4) at any intestinal site (Table 5). Valerate
and the branched SCFAs could not be detected in the digesta samples of the distal small
intestine.
Calprotectin
Calprotectin concentration, a marker for intestinal inflammation, was determined in fecal
samples taken at d 7, d 21.5 and d 36.5 and in blood samples collected at d 36.5. Calprotectin
levels were below the detection limit in all blood samples and in fecal samples collected at d 7
and d 21.5. At 2 weeks post-weaning, calprotectin was only detected in some of the fecal sam-
ples. Given the high number of samples with values below the detection limit (these samples
were recorded as 0 μg/g feces) and the resulting high variability, we failed to detect a statisti-
cally significant difference regarding the concentration of calprotectin between the different
treatment groups in spite of the numerical difference (CON: 157 ± 76 μg/g feces (in 4/8 sam-
ples calprotectin was below the limit of detection); T1: 75 ± 29 μg/g feces (in 3/8 samples cal-
protectin was below the limit of detection); T2: 94 ± 38 μg/g of feces (in 4/8 samples
calprotectin was below the limit of detection)) (p = 0.8).
Table 5. Concentrations of short-chain fatty acids and lactate acid (mean ± SEM) in d 36.5 digesta of NBW piglets that received scFOS or not.
CON1 T11 T21 P2
(n = 7) (n = 8) (n = 8)
Distal small intestine
Total SCFA (μM/g) 1.49 ± 0.23 1.43 ± 0.13 1.75 ± 0.29 0.71
Acetate (μM/g) 1.34 ± 0.19 1.46 ± 0.20 1.64 ± 0.27 0.78
Proprionate (μM/g) 0.031 ± 0.003 0.029 ± 0.007 0.027 ± 0.003 0.79
Butyrate (μM/g) 0.065 ± 0.012 0.067 ± 0.012 0.078 ± 0.017 0.98
Lactic acid (μM/g) 12.8 ± 2.8 19.9 ± 5.2 15.1 ± 3.4 0.41
Mid colon
Total SCFA (μM/g) 10.47 ± 0.12 10.30 ± 0.72 11.15 ± 0.71 0.79
Acetate (μM/g) 6.84 ± 0.30 6.28 ± 0.42 6.93 ± 0.32 0.45
Proprionate (μM/g) 2.67 ± 0.08 2.61 ± 0.23 2.82 ± 0.28 0.86
Butyrate (μM/g) 2.13 ± 0.88 1.07 ± 0.16 1.26 ± 0.21 0.16
Valerate (μM/g) 0.28 ± 0.14 0.17 ± 0.03 0.15 ± 0.02 0.88
Isobutyrate (μM/g) 0.009 ± 0.001 0.007 ± 0.001 0.009 ± 0.001 0.33
Isovalerate (μM/g) 0.120 ± 0.023 0.095 ± 0.016 0.120 ± 0.016 0.55
Lactic acid (μM/g) 8.39 ± 0.14 8.13 ± 0.13 8.33 ± 0.27 0.42
1Treatments: CON = Piglets drenched with 2 mL tap water until d 7; T1 = Piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-
Meiji) dissolved in 2 mL tap water until d 7; T2 = Piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age).
2P-value of the comparison between the 3 treatments.
https://doi.org/10.1371/journal.pone.0233910.t005
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IgG
IgG levels in blood samples collected at 36.5 d were not different between the treatment groups
(CON: 18.9 ± 3.3 ng/mL; T1: 27.9 ± 4.5 ng/mL; T2: 22.3 ± 4.4 ng/mL) (p = 0.2).
Intestinal function: Morphometry, barrier function
Since small intestine dimensions are an important determinant for the digestive capacity of
the gut, both macroscopic and microscopic parameters were determined on NBW samples
taken on d 36.5.
The length of the small intestine did not differ between the treatment groups (CON:
1,022 ± 22 cm; T1: 985 ± 28 cm; T2: 1,086 ± 48 cm) (p = 0.2) nor was its relative length
(expressed as cm/kg body weight at d 36.5) affected by the intake of scFOS (CON: 113 ± 6 cm/
kg; T1: 146 ± 16 cm/kg; T2: 132 ± 7 cm/kg) (p = 0.093).
Similarly, the length of the villi (p = 0.2) as well as the depth of the crypts at the level of the
distal small intestine (p = 0.5) and of the mid colon (p = 0.9) of 36.5 day old piglets were not
affected by the supplementation with scFOS (Fig 4).
Closely related to villus length and crypt depth is the ratio between mitosis and apoptosis.
In this experiment an estimate of this ratio was carried out by determining the relative (to ß-
actin) presence of proliferating cell nuclear antigen (PCNA) and caspase-3 (Fig 4). Both pro-
teins had a higher relative abundance in the small intestine when compared to the large intes-
tine (PCNA: p = 0.003; caspase-3: p = 0.009). Irrespective of intestinal location, none of them
was affected by the supplementation with scFOS (PCNA: p = 0.6; caspase-3: p = 0.2).
More IEL were present in the small intestine when compared with the colon (p< 0.001).
This regional difference and the overall presence of IEL was unaffected by scFOS supplementa-
tion (p = 0.9) (Fig 5).
The intestinal barrier function was evaluated by the ex vivo translocation of FD-4 from the
mucosal to the serosal side of the intestine. The Papp of FD-4 (2.35x10-6 ± 0.37x10-6 cm/s) did
not differ between treatment groups and between the small and large intestine (Table 6).
Tight junctions seal enterocytes together and modulate transcellular movement of mole-
cules. Immunohistochemical staining against key-constituents of the tight junction complex
(OCLN, ZO-1 and CLDN-2) (S1 Fig) revealed the presence of tight junctions in the small and
large intestine in the samples of the different treatment groups (data not shown). OCLN-
immunoreactivity (IR) formed a more or less continuous band lining the villus and villus base.
ZO-1-IR and CLDN-2-IR showed a more patchy staining which was limited to the villus. In
the colon, OCLN-, ZO-1- and CLDN-2-IR were seen at the mucosa surface. OCLN-IR was
present in the top half of the crypts. ZO-1-IR was also seen in cells in the lamina mucosae of
the mid colon region.
mRNA gene expressions
The mRNA gene expression profile in the intestine did not show any regional differences, nor
was the effect of treatment region-dependent. Supplementation with scFOS modified the
abundance of IFNγ mRNA (p = 0.025), which was significantly higher in the group of piglets
that received scFOS for 7 days after birth compared to the piglets that were drenched with tap
water. All other mRNA expression values were similar accross the treatment groups (Table 7).
Discussion
Low birth weight piglets showed worse performance (as indicated by the results for body
weight, colostrum intake, average daily gain and mortality) compared to NBW and HBW,
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which complies with literature [2, 12–15]. The causal relationship between BiW on the one
hand and ADG on the other hand has been shown by various other reports [2, 3, 12–15] and
explains why LBW piglets fail to catch up with their littermates. Nevertheless this does not pre-
clude that some of the piglets born with a LBW level up their performance and catch up later
during the nursing phase [4, 16, 17]. In agreement with this, we observed that 22% of the LBW
piglets in this study reached a post-weaning weight that fell in the two intermediate quartiles,
while a 17% of NBW piglets had their body weight within the upper quartile at the end of the
experiment. Given this window of opportunity, we hypothesized that drenching of short-chain
fructo-oligosaccharides (scFOS) would lead to a better performance, especially in the LBW
piglets. However, scFOS supplementation did not impact performance during the experimen-
tal period in LBW piglets. On the contrary, in NBW piglets, a treatment effect was observed
with an increase in the body weight with the higher duration of scFOS supplementation. Simi-
lar inconsistent results have been reported in the literature. For example, the direct supple-
mentation of FOS to piglets during the lactation period has been shown to increase [24]
[50], but also decrease [51] growth. It has also been demonstrated that maternal scFOS
Fig 4. Villus lenght (white bar; mean + SE), crypt depth (grey bar; mean + SE) and number of intra-epithelial lymphocytes
(IEL) per 100 μm villus lenght (full circle; mean ± SE) in the distal small intestine (SI) and crypt depth and number of IEL per
100 μm crypt depth in the mid colon (C) of CON (piglets drenched with 2 mL tap water until d 7) (n = 7), T1 (piglets drenched
with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-Meiji) dissolved in 2 mL tap water until d 7) (n = 8)
and T2 (piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age) (n = 8)) at 36.5 days of age. No
differences were observed between the different treatment groups for villus length, crypt depth and IELs/100 μm.
https://doi.org/10.1371/journal.pone.0233910.g004
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supplementation did not affect the growth of piglets during lactation [18, 22, 25, 26, 34] with
controversial beneficial effects on growth after weaning [18, 22, 25, 26, 34]. These conflicting
results indicate that the outcome of FOS supplementation may be affected by age, BiW, diet,
administration route and even health status of the animals [52, 53]. In the present study, we
accounted for some of these factors by including different BiW categories and different dura-
tions of supplementation during the suckling period (for 7 or for 21 days of age).
We observed rather high mortality rates (16.5%) in our experiment, especially during the
suckling phase. This could be due to the use of highly prolific sows in the experiment (only
Fig 5. Normalized OD (relative to ß-actin OD) of PCNA (black bar; mean + SEM) and caspase- 3 (white bar; mean + SEM) in
the distal small intestine (SI) and in the mid colon (C) of CON (piglets drenched with 2 mL tap water until d 7; n = 7), T1
(piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-Meiji) dissolved in 2 mL tap
water until d 7; n = 8) and T2 (piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age); n = 8)
at 36.5 days of age. No differences were observed between the treatment groups. The normalized OD of PCNA and caspase-3 were
significantly higher in the small intestine when compared to the colon.
https://doi.org/10.1371/journal.pone.0233910.g005
Table 6. Effects of drenching with scFOS on apparent permeability for FITC-dextran, 4kDa (mean ± SEM) in distal small intestine and mid colon on day 36.5 of life
of NBW piglets.
Papp FITC-dextran (cm/s 10−7) CON1 T11 T21 p-value p-value
(n = 7) (n = 8) (n = 8) Treatment Location
Distal small intestine 21.9 ± 9.0 20.0 ± 5.8 16.6 ± 6.2 0.87 0.70
Mid colon 32.5 ± 15.4 23.2 ± 9.4 28.9 ± 9.2 0.85
1Treatments: CON = Piglets drenched with 2 mL tap water until d 7; T1 = Piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-
Meiji) dissolved in 2 mL tap water until d 7; T2 = Piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age).
https://doi.org/10.1371/journal.pone.0233910.t006
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litters with more than 14 piglets were included), with a large number of LBW pigs and a low
average piglet BiW per litter, but also due to the fact that we limited piglet’s handling in order
to not interfere with the scFOS treatment. This high pre-weaning mortality could not be
reduced by supplementation with scFOS. One could conjecture, also considering the larger
effects regarding growth were observed in NBW than LBW piglets, that the efficacy of scFOS is
limited in very compromised piglets. The presence of high numbers of very compromised pig-
lets during the suckling period–in our setting in the LBW group–may have reduced the chance
to observe effects of scFOS supplementation. Alternatively, it could also be possible that scFOS
need a longer supplementation time or higher concentration for positive effects to be observed
(see later). Despite the lack of effects during suckling, one of the most interesting results found
in our study, especially from an economic point of view, is the significant reduction in post-
weaning mortality after scFOS supplementation for 7 or 21 days. This has been previously
reported [54] and represents a clear gain for the pig industry. This effect was clearly observed
in NBW piglets, in agreement with results in ADG and body weight, that pinpoints this BiW
category as the most responsive to the treatment. However, LBW piglets seem to be responsive
as well, with no piglets dying in the last 2 weeks of the experiment. It is striking that these dif-
ferences are only observed in the postweaning period.
Interestingly, we did not observe any difference in mortality rate between BiW categories
after weaning, contrary to the lower mortailty observed in suckling HBW when compared to
LBW and NBW piglets. This a consequence of a reduction in mortality observed in all BiW
categories, but especially in LBW (from 30.6% to 7.4% mortality) and NBW (from 24.2% to
9.6% mortality) piglets. This is most likely a consequence of the higher mortality observed in
the first weeks of age, mostly attributed to the starvation-crushing-hypothermia complex [3],
with the weakest piglets dying in this period and thus, not reaching the postweaning phase.
These weakest piglets were probably too weak to benefit from possible beneficial effects of
scFOS. Whereas those piglets which survived the suckling period, are reaching the threshold
resilience that can be uplifted via scFOS resulting in a better post-weaning survival. In addition
to performance parameters, and to gain more understanding on the mode of action of scFOS
on performance and health, we studied the effects of scFOS on different parameters related to
gut health.
Table 7. Effects of drenching with scFOS on the expression of mRNA (mean ± SEM) related to digestion and inflammation in NBW piglets.
Item1 CON2 T12 T22 P3
(n = 7) (n = 8) (n = 8)
MUC2 1.60 ± 0.30 1.17 ± 0.27 1.12 ± 0.22 0.4
IAP 1.07 ± 0.20 0.72 ± 0.18 1.28 ± 0.35 0.4
IL-1ß 1.06 ± 0.17 0.86 ± 0.13 0.95 ± 0.15 0.7
IL-6 1.41 ± 0.29 1.26 ± 0.30 1.23 ± 0.14 0.8
IL-10 0.82 ± 0.07 1.02 ± 0.12 1.00 ± 0.14 0.7
IFNγ 0.67 ± 0.15a 1.25 ± 0.21b 0.75 ± 0.12a,b 0.025
TNFα 1.38 ± 0.23 0.94 ± 0.11 1.13 ± 0.12 0.2
TLR-4 1.49 ± 0.24 1.30 ± 0.16 1.43 ± 0.17 0.5
1MUC2, mucin 2; IL-1β, interleukin 1 beta; IL-6, interleukin 6; TNF-α, tumor necrosis factor, alpha; IFN-γ, interferon gamma; IL-10, interleukin 10; TLR-4, toll-like
receptor-4; IAP, intestinal alkaline phosphatase.
2Treatments: CON = Piglets drenched with 2 mL tap water until d 7; T1 = Piglets drenched with 1 g short-chain fructo-oligosaccharides (scFOS, Profeed P95, Beghin-
Meiji) dissolved in 2 mL tap water until d 7; T2 = Piglets drenched with 1 g scFOS dissolved in 2 mL tap water until d 21.5 (weaning age).
3P-value of the comparison between the 3 treatments. Means with different superscript are significantly different (p� 0.05).
https://doi.org/10.1371/journal.pone.0233910.t007
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The health-promoting effects of FOS are mostly linked to their direct bifidogenic effects
[23, 24, 50]. Schokker et al. showed an increase in the abundance of Bifidobacteria in digesta
samples after 10 days of supplementing both scFOS (9 g per day) and long-chain FOS (1 g per
day) to suckling piglets [24]. Similarly, Shim et al. saw a rise of Bifidobacteria in digesta sam-
ples of suckling piglets fed creep feed rich in scFOS from day 7 for either 10 days or until wean-
ing [50]. In our study, piglets received 1 g scFOS from birth until day 7 of life or until weaning
and fecal samples were used to describe the composition of the microbiome. In both regimens,
no significant difference in diversity and composition of the microbiome between the treat-
ment and control groups were seen, not even for several taxa commonly associated with fiber
consumption—including Lactobacillus spp., Bifidobacteriaceae, and butyrate-producing Mega-
sphaera. Possible explanations for the absence of a detectable bifidogenic effect in this study
could lay in the sample (feces vs digesta) and dosage of scFOS [52]. We opted for fecal samples
to longitudinally follow the changes in the microbiome. In addition, the Bifidobacteria popula-
tion in pigs is significantly lower than in humans, representing less than 0.1% of total
sequences in fecal samples of 22-week-old pigs [55]. Although Bifidobacteria are usually con-
sidered the primary target, scFOS can additionally affect other gut bacteria. We observed a
temporary decline in the relative abundance of Bacteroides when the piglets received scFOS
and a significant increase with age in the presence of Prevotella which was unrelated to scFOS
intake. Similar to our observations, Schokker and co-workers saw a temporary decline in the
abundance of Bacteroides and a rise in Prevotella in the piglets fed scFOS [24]. In a study of Le
Bourgot, where sows were supplemented with scFOS and the offspring received dietary scFOS
up till 1 month after weaning, again a decrease in Bacteroides and a relative increase in Prevo-
tella in the fecal microbiome of the suckling offspring was observed, which persisted into
adulthood [34]. It should be noted that in both studies the intake of scFOS was either substan-
tially higher in dosage [24] or longer [34] than in our study which could explain the minor and
temporary changes observed in our study. Notwithstanding we did not observe a clear bifido-
genic effect, the slight changes observed in the bacterial population reflect an adaptation of the
microbiome to changes in the diet (these being scFOS supplementation or weaning) [56, 57].
Most of the effects of scFOS on gut health are attributed to the fermentation of the oligosac-
charides into SCFA’s by the adapted gut microbiome [18, 19, 23, 24, 26, 56]. The main fermen-
tation products of FOS are proprionate and acetate [34, 56, 58] that affect gut health via
different mechanisms [34, 59]. Le Bourgot demonstrated that the increased proportion of Pre-
votella in suckling piglets of sows that receive scFOS resulted in increased concentrations of
acetate, propionate but also valerate and caproate at weaning. However—in accordance with
our results on the microbiome—the metabolic profile (detailing the concentrations of SCFAs)
of digesta and fecal samples was not different between the treatment groups. Nevertheless, the
concentrations of the SCFAs in feces changed with age, compliant with other reports and illus-
trating the relative increase in Prevotella in the gut’s microbiome and the adaptation to a diet
high in carbohydrates [57].
The supplementation of scFOS was expected to affect different functional morphological
characteristics of gut health by means of an increase or change in the composition of the SCFAs
[59]. In our study both short- and long-term supplementation of 1 g scFOS did not affect intes-
tinal integrity (determined by measuring intestinal permeability (FD-4-translocation in Ussing
chambers), immunohistochemistry against occludin, ZO-1, claudin-2, and real time qPCR for
MUC2), regenerative capacity (Western blot PCNA and caspase-3), and intestinal architecture
(villus lenght, crypt depth). It should be mentioned these results were obtained in a subset of the
piglets that all had a normal BiW. These results are consistent with the lack of a clear effect of
scFOS on the microbiome and SCFAs production. Several studies that saw a bifidogenic effect
of FOS in the pig, reported different effects on intestinal architecture [24, 26, 60].
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Previous research has shown that FOS could exert microbiota-independent effects, on espe-
cially the maturing immune system [20]. In these studies it was shown that FOS given to
young animals (infant mice or piglets) increased IgA secretion [33, 34], cytokine release (espe-
cially IFNγ) [33–35] and the number of natural killer cells and memory T cells [35] at the level
of the intestine. These are interesting observations in view of the targeted decrease in post-
weaning mortality via scFOS supplementation. Due to the lack or the very scarce effects on the
microbiome, the intestinal morphology or its structural integrity, we hypothesize that scFOS
excerted non-microbiome related effects that improved the maturation of the (intestinal)
immune system. In order to get an idea of the impact of scFOS on the intestinal immune
response, the serum levels of IgG, the density of intra-epithelial lymphocytes, and the expres-
sion profiles for several immune system-related genes (IL-10, IL-1ß, IL-6, TNFα and IFNγ)
were estimated. Reports on the effects of FOS on the immune system under healthy conditions
disagree. Most reports in pigs and mice clearly observed increased levels of immunoglobulins,
cytokines and especially CD4 cells [33, 34, 61, 62]. In our study, we only observed a numerical
increase in IgG levels (without joining significance) while the density of intra-epithelial lym-
phocytes was not differing between the treatment groups. Fukusawa and co-workers suggested
potential genetic markers–of which interferon (IFN) was important—to study the immuno-
modulating effects of FOS [63]. Similar to others [63, 64], IFNγ mRNA levels were upregulated
in piglets that received scFOS whereas the mRNA levels of the other cytokines remained
unchanged. It is to be expected that the increased mRNA level of IFNγ leads to an increased
release of this cytokine, since others already showed an increase concentration of IFNγ in ileal
mucosa in case of maternal supplementation of scFOS [18, 26]. However, it is doubtable that
the sole upregulation of IFNγ expression indicates an inflammatory status given the fact that
we did not observe any indication of gastrointestinal dysfunction (i.c. no indication of diar-
rhea, no differences in the levels of calprotectin, which is an inflammatory marker). Increased
IFNγ mRNA can rather indicate—as suggested by others—that scFOS partakes in the matura-
tion of the immune system via a polarization of the Th1 immune response [18, 35, 65] which
suggests a more mature immune system in scFOS-supplemented piglets. The combination of a
better immunity in supplemented piglets together with the increased presence of Prevotella
observed in all piglets included in this study, could drive the decrease in post-weaning mortal-
ity observed after a low dose supplementation of scFOS to suckling piglets. Moreover it should
be mentioned that the increased presence of Prevotella is of interest since an enterotype rich in
Prevotallaceae, Lachnospiraceae, Ruminocacaceae and Lactobacillaceae decreases the suscepti-
bility to post-weaning diarrhea [57, 66].
In general, inconsistent results have been reported in literature regarding the beneficial
effect of supplementation of scFOS to suckling and weaning piglets. In a study assessing the
effects of scFOS supplementation to the sow and to the offspring on SCFA and other intestinal
health markers, it was observed that no additional benefit was obtained when supplementation
to the offspring was continued after weaning [23]. Thus, scFOS seem to be more effective
when administered to the perinatal sow than to the offspring. In agreement with that, results
reporting the prebiotic effects of FOS and mannan-oligosaccharides are more consistent when
administered to the sow rather than the offspring [67, 68]. We can speculate that changes in
the microbiome are more difficult in the suckling piglet. Also, there is limited information
available regarding the structure and function of the gut microbiome of piglets in early-life in
association with health and growth performance. It has been observed that bacterial popula-
tions remain similar after different rearing conditions (suckling vs formula) in the first 5 days
of life, after which milk composition affected the piglets’ microbiome [69, 70]. Moreover, a
sequential change in microbiome occurs during early life, with a very limited number of bacte-
ria genera present in the first days of life that increase during the colonization process [71].
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This reduced abundance in bacteria genera may limit the beneficial effects of scFOS in the
early postnatal period. Also, the immaturity of the gut and the changes in gut morphology
experienced during the first weeks of life could impair the use of prebiotics by the microbiome.
However, previous studies demonstrated that formula-fed babies supplemented with oligosac-
charides showed a change in the bacterial population [72, 73]. Another reason for the inconsis-
tency of results could be the effect of the food matrix on the efficacy and bacterial use of these
non-digestible fibers. In contrast with our experimental set-up, where piglets received scFOS
independently of milk/creep feed consumption, results in babies where FOS was added
directly to milk formula, report a more marked effect on bacterial populations [72, 73],
although a similar set up in neonatal piglets only led to a trend in the increase of Bifidobacteria
[74]. Also, rats given FOS in combination with probiotics showed a an increased gut perme-
ability when fed a highly digestible but not a normal diet [53]. Regardless of the aforemen-
tioned constraints (i.e. dose, experimental conditions and administration route), our set up
has the advantage of allowing the direct administration of a precise low dose to all the animals
included in the study, independent of their daily food intake.
Based on the variety of experimental conditions and results, it seems several factors are
implicated in the efficacy of scFOS in promoting (intestinal) health. Moreover, it cannot be
ruled out that scFOS will exert a more pronounced effect when given at higher doses (as
reported previously), a different administration route and/or under not optimal environmen-
tal conditions. Further studies are necessary to unravel the different mechanisms of action that
may be implicated when scFOS are supplemented to adults and young animals. This may help
to identify the right stage for scFOS supplementation (i.e. suckling versus weaning) based on
the desired outcomes.
Conclusions
Giving a low dose of scFOS (1 g/day per piglet) improved growth of suckling piglets and
reduced post-weaning mortality to 0%, which supports the view that scFOS positively impact
piglet’s health and resilience. However, the increased body weight after supplementation was
only observed in piglets born with a body weight between the 25% and 75% quartiles (NBW)
and not in LBW piglets, as was hypothesized. Moreover, the modes of action for these effects
are not yet fully elucidated, since the effects of such dose on gut health in our experimental
conditions are subtle. Further field research is granted in order to optimize scFOS dosage
based on the expected outcome (i.e. mortality, ADG), the length of the treatment, the age and
the handling/sanitary challenges to which piglets are exposed to.
Supporting information
S1 Fig. A view on a paraffin section of a small intestinal sample of a piglet that received
Profeed L95 (1 g scFOS per day and per pig) until weaning by drenching (left panel). A pos-
itive immunohistochemical staining against occludin (1A), cloudin 2 (1B) and ZO-1 (1C) just
below the brush border can be seen at the level of the villus tip (cloudin 2), and at the villus tip
and body (occludin and ZO-1).
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